Gilead Sciences has implemented measures to protect the personal information you provide. Please see the Gilead
Privacy Statement
for more information about how Gilead handles your personal information and your rights

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable. Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via drugsafety.dubai@gilead.com

For any questions related to Gilead products or therapeutic areas, please contact askgileadME@gilead.com

Emailer is created for healthcare professionals only.